BTAI Insider Transactions
158 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
BTAI insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Yocca Frank | Chief Scientific Officer | 2026-05-20 | Sale | 6,845.0 | $1.09 |
| Rodriguez Javier | See Remarks | 2026-05-20 | Sale | 6,560.0 | $1.08 |
| Steinhart Richard I | Chief Financial Officer | 2026-05-20 | Sale | 6,845.0 | $1.09 |
| Mehta Vimal | CEO and President | 2026-05-20 | Sale | 19,419.0 | $1.09 |
| O'Neill Vincent | See Remarks | 2024-12-16 | Sale | 165.0 | $0.35 |
| Mehta Vimal | CEO and President | 2024-12-16 | Sale | 2,134.0 | $0.36 |
| Mehta Vimal | CEO and President | 2024-12-16 | Sale | 983.0 | $0.36 |
| Steinhart Richard I | Chief Financial Officer | 2024-12-16 | Sale | 372.0 | $0.36 |
| Steinhart Richard I | Chief Financial Officer | 2024-12-16 | Sale | 205.0 | $0.36 |
| Rodriguez Javier | See Remarks | 2024-12-16 | Sale | 220.0 | $0.36 |
| Rodriguez Javier | See Remarks | 2024-12-16 | Sale | 210.0 | $0.36 |
| Yocca Frank | Chief Scientific Officer | 2024-12-16 | Sale | 225.0 | $0.35 |
| Yocca Frank | Chief Scientific Officer | 2024-12-16 | Sale | 205.0 | $0.36 |
| Wiley Matthew T. | Chief Commercial Officer | 2024-10-03 | Sale | 6,272.0 | $0.55 |
| Rodriguez Javier | See Remarks | 2024-10-03 | Sale | 6,863.0 | $0.55 |
| Yocca Frank | Chief Scientific Officer | 2024-10-03 | Sale | 7,175.0 | $0.55 |
| Steinhart Richard I | Chief Financial Officer | 2024-10-03 | Sale | 7,175.0 | $0.55 |
| O'Neill Vincent | See Remarks | 2024-10-03 | Sale | 5,556.0 | $0.55 |
| Yocca Frank | Chief Scientific Officer | 2024-09-16 | Sale | 355.0 | $0.69 |
| Mehta Vimal | CEO and President | 2024-09-16 | Sale | 1,150.0 | $0.69 |
| Mehta Vimal | CEO and President | 2024-09-16 | Sale | 832.0 | $0.69 |
| Steinhart Richard I | Chief Financial Officer | 2024-09-16 | Sale | 356.0 | $0.69 |
| Rodriguez Javier | See Remarks | 2024-09-16 | Sale | 345.0 | $0.69 |
| O'Neill Vincent | See Remarks | 2024-09-16 | Sale | 138.0 | $0.69 |
| Wiley Matthew T. | Chief Commercial Officer | 2024-09-16 | Sale | 215.0 | $0.69 |
| Yocca Frank | Chief Scientific Officer | 2024-06-17 | Sale | 372.0 | $1.28 |
| Wiley Matthew T. | Chief Commercial Officer | 2024-06-17 | Sale | 244.0 | $1.26 |
| Steinhart Richard I | Chief Financial Officer | 2024-06-17 | Sale | 372.0 | $1.26 |
| Rodriguez Javier | See Remarks | 2024-06-17 | Sale | 361.0 | $1.26 |
| O'Neill Vincent | See Remarks | 2024-06-17 | Sale | 155.0 | $1.29 |
| Mehta Vimal | CEO and President | 2024-06-17 | Sale | 2,134.0 | $1.28 |
| BioXcel LLC | TenPercentOwner | 2024-06-05 | Sale | 126,014.0 | $1.58 |
| Mehta Vimal | CEO and President | 2024-06-05 | Sale | 126,014.0 | $1.58 |
| BioXcel Holdings, Inc. | TenPercentOwner | 2024-06-05 | Sale | 126,014.0 | $1.58 |
| BioXcel LLC | TenPercentOwner | 2024-06-05 | Sale | 283,122.0 | — |
| Mehta Vimal | CEO and President | 2024-06-05 | Sale | 283,122.0 | — |
| BioXcel Holdings, Inc. | TenPercentOwner | 2024-06-05 | Sale | 283,122.0 | — |
| BioXcel LLC | TenPercentOwner | 2024-06-04 | Sale | 126,014.0 | $1.63 |
| Mehta Vimal | CEO and President | 2024-06-04 | Sale | 126,014.0 | $1.63 |
| BioXcel Holdings, Inc. | TenPercentOwner | 2024-06-04 | Sale | 126,014.0 | $1.63 |
| BioXcel LLC | TenPercentOwner | 2024-06-04 | Sale | 283,123.0 | — |
| Mehta Vimal | CEO and President | 2024-06-04 | Sale | 283,123.0 | — |
| BioXcel Holdings, Inc. | TenPercentOwner | 2024-06-04 | Sale | 283,123.0 | — |
| BioXcel LLC | TenPercentOwner | 2024-06-04 | Sale | 609,221.0 | — |
| Mehta Vimal | CEO and President | 2024-06-04 | Sale | 609,221.0 | — |
| BioXcel Holdings, Inc. | TenPercentOwner | 2024-06-04 | Sale | 609,221.0 | — |
| O'Neill Vincent | See Remarks | 2024-04-04 | Sale | 165.0 | $2.62 |
| Mehta Vimal | CEO and President | 2024-04-04 | Sale | 4,439.0 | $2.62 |
| Mehta Vimal | CEO and President | 2024-04-04 | Sale | 829.0 | $2.62 |
| Steinhart Richard I | Chief Financial Officer | 2024-04-04 | Sale | 1,069.0 | $2.64 |
| Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | 2024-04-04 | Sale | 1,008.0 | $2.64 |
| Rodriguez Javier | See Remarks | 2024-04-04 | Sale | 1,012.0 | $2.64 |
| Yocca Frank | Chief Scientific Officer | 2024-04-04 | Sale | 1,067.0 | $2.64 |
| Mehta Vimal | CEO and President | 2023-06-16 | Sale | 747.0 | $21.89 |
| Mehta Vimal | CEO and President | 2023-06-16 | Sale | 4,266.0 | $20.9 |
| Mehta Vimal | CEO and President | 2023-06-16 | Sale | 24,987.0 | $20.01 |
| Mehta Vimal | CEO and President | 2023-06-15 | Sale | 8,012.0 | $21.9 |
| Mehta Vimal | CEO and President | 2023-06-15 | Sale | 21,988.0 | $21.41 |
| Mehta Vimal | CEO and President | 2023-05-22 | Sale | 6,500.0 | $25.79 |
| Steinhart Richard I | Chief Financial Officer | 2023-05-15 | Sale | 5,000.0 | $27.17 |
| Rodriguez Javier | See Remarks | 2023-05-15 | Sale | 1,785.0 | $27.32 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2023-04-06 | Sale | 60,000.0 | $17.32 |
| Mehta Vimal | CEO and President | 2023-03-21 | Sale | 900.0 | $20.15 |
| Mehta Vimal | CEO and President | 2023-03-21 | Sale | 29,100.0 | $19.7 |
| Mehta Vimal | CEO and President | 2023-03-20 | Sale | 604.0 | $18.88 |
| Mehta Vimal | CEO and President | 2023-03-20 | Sale | 3,896.0 | $18.22 |
| Mehta Vimal | CEO and President | 2023-03-20 | Sale | 5,333.0 | $18.86 |
| Mehta Vimal | CEO and President | 2023-03-20 | Sale | 24,667.0 | $18.2 |
| Steinhart Richard I | Chief Financial Officer | 2023-03-15 | Sale | 2,084.0 | $19.5 |
| Yocca Frank | Chief Scientific Officer | 2023-03-15 | Sale | 985.0 | $19.69 |
| O'Neill Vincent | Chief Medical Officer | 2023-03-15 | Sale | 845.0 | $19.7 |
| Rodriguez Javier | See Remarks | 2023-03-15 | Sale | 950.0 | $19.63 |
| Yocca Frank | Chief Scientific Officer | 2023-01-20 | Sale | 50,000.0 | $30.0 |
| O'Neill Vincent | Chief Medical Officer | 2023-01-20 | Sale | 29,713.0 | $30.0 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2023-01-05 | Sale | 800.0 | $22.93 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2023-01-05 | Sale | 25,089.0 | $22.32 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2023-01-04 | Sale | 9,821.0 | $22.21 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2023-01-04 | Sale | 24,290.0 | $21.59 |
| Mehta Vimal | CEO and President | 2022-12-16 | Sale | 9,887.0 | $19.92 |
| Mehta Vimal | CEO and President | 2022-12-16 | Sale | 20,113.0 | $19.21 |
| Mehta Vimal | CEO and President | 2022-12-15 | Sale | 7,206.0 | $20.19 |
| Mehta Vimal | CEO and President | 2022-12-15 | Sale | 22,794.0 | $19.86 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2022-11-11 | Sale | 32,550.0 | $15.0 |
| Nandabalan Krishnan | Director,TenPercentOwner | 2022-11-10 | Sale | 27,450.0 | $15.0 |
| Mehta Vimal | CEO, President and Secretary | 2021-06-25 | Sale | 473,250.0 | $30.83 |
| Nandabalan Krishnan | Director | 2021-06-25 | Sale | 473,250.0 | $30.83 |
| BioXcel LLC | TenPercentOwner | 2021-06-25 | Sale | 473,250.0 | $30.83 |
| BioXcel Holdings, Inc. | TenPercentOwner | 2021-06-25 | Sale | 473,250.0 | $30.83 |
| Yocca Frank | Chief Scientific Officer | 2021-03-15 | Sale | 630.0 | $49.3 |
| Yocca Frank | Chief Scientific Officer | 2021-03-15 | Sale | 14,370.0 | $48.47 |
| O'Neill Vincent | Chief Medical Officer | 2021-02-17 | Sale | 600.0 | $57.17 |
| O'Neill Vincent | Chief Medical Officer | 2021-02-17 | Sale | 9,573.0 | $56.6 |
| O'Neill Vincent | Chief Medical Officer | 2021-02-17 | Sale | 6,872.0 | $55.55 |
| O'Neill Vincent | Chief Medical Officer | 2021-02-17 | Sale | 5,655.0 | $54.45 |
| O'Neill Vincent | Chief Medical Officer | 2021-02-17 | Sale | 2,300.0 | $53.77 |
| Yocca Frank | Chief Scientific Officer | 2021-02-16 | Sale | 600.0 | $61.2 |
| Yocca Frank | Chief Scientific Officer | 2021-02-16 | Sale | 1,772.0 | $60.43 |
| Yocca Frank | Chief Scientific Officer | 2021-02-16 | Sale | 500.0 | $59.46 |
| Yocca Frank | Chief Scientific Officer | 2021-02-16 | Sale | 2,886.0 | $58.54 |
| Yocca Frank | Chief Scientific Officer | 2021-02-16 | Sale | 1,137.0 | $57.71 |